The Effect of Posttranslational Modifications on the in Vitro Activity of Recombinant Human Thyroid-Stimulating Hormone

Thyroid

Volumn 13, Issue 12, 2003, Pages 1091-1101

  Sendak, Rebecca A ^a   Ganesa, Chandrashekar ^a   Lee, Karen L ^a   Harrahy, John J ^a   Théberge, Roger ^a   Morgan, Charles J ^a   Cole, Edward S ^a   Kohn, Leonard D ^b   Mattaliano, Robert J ^a  

^a GENZYME CORPORATION   (United States)

^b OHIO UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; METHIONINE DERIVATIVE; OLIGOSACCHARIDE; RECOMBINANT THYROTROPIN; SIALIC ACID; TERT BUTYL HYDROPEROXIDE;

ARTICLE; BETA CHAIN; CARBOXY TERMINAL SEQUENCE; CORRELATION ANALYSIS; DRUG ACTIVITY; HORMONE ACTION; IN VITRO STUDY; MASS SPECTROMETRY; OXIDATION; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN PROCESSING;

EID: 0347993695     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/10507250360731488     Document Type: Article

References (21)

1. Grossman M, Weintraub BD, Szkudlinski MW 1997 Novel insights into the molecular mechanisms of human thyrotropin action: Structural, physiological, and therapeutic implications for the glycoprotein hormone family. Endocr Rev 18:476-501.
2. Pierce JG, Parsons TF 1981 Glycoprotein hormones: Structure and function. Annu Rev Biochem 50:465-495.
3. Szkudlinski MW, Grossman M, Leitolf H, Weintraub BD 2000 Human thyroid-stimulating hormone: Structure-function analysis. Methods 21:67-81.
4. Cole ES, Lee K, Lauziere K, Kelton C, Chappel S, Weintraub B, Ferrara D, Peterson P, Bernasconi R, Edmunds T, Richards S, Pratt BM 1993 Recombinant human thyroid stimulating hormone: Development of a biotechnology product for detection of metastatic lesions of thyroid carcinoma. Biotechnology 11:1014-1024.
5. Takata K-I, Watanabe S, Hirono M, Tamaki M, Teraoka H, Hayashizaki Y 1989 The role of the carboxyl-terminal 6 amino acid extension of human TSH β subunit. Biochem Biophys Res Commun 165:1035-1042.
6. Cumming DA 1991 Glycosylation of recombinant protein therapeutics: Control and functional implications. Glycobiology 1:115-130.
7. Keck R 1996 The use of t-butyl hydroperoxide as a probe for methionine oxidation in proteins. Anal Biochém 236:56-62.
8. Konz JO, King J, Cooney CL 1998 Effects of oxygen on recombinant protein expression. Biotechnol Prog 14:393-409.
9. Sairam MR, Li C-H 1977 Human pituitary thyrotropin. The primary structure of the alpha and beta subunits. Can J Biochem 55:755-760.
10. Hayashizaki Y, Miyai K, Kato K, Matsubara K 1985 Molecular cloning of the human thyrotropin-beta subunit gene. FEBS Lett 188:394-400.
11. Morris JC, McCormick DJ, Ryan RJ 1990 Inhibition of thyrotropin binding to receptor by synthetic human thyrotropin beta peptides. J Biol Chem 265:1881-1884.
12. Szkudlinski MW, Thotakura NR, Bucci I, Joshi LR, Tsai A, East-Palmer J, Shiloach J, Weintraub B 1993 Purification and characterization of recombinant human thyrotropin isoforms produced by Chinese hamster ovary cells: The role of sialylation and sulfation in TSH bioacfivity. Endocrinology 133:1490-1503.
13. Van Patten SM, Hanson E, Bernasconi R, Zhang K, Manavalan P, Cole ES, McPherson JM, Edmunds T 1999 Oxidation of methionine residues in antithrombin. J Biol Chem 274:10268-10276.
14. Chowdhury SK, Eshraghi J, Wolfe H, Forde D, Hlavac AG, Johnston D 1995 Mass spectrophotometric identification of amino acid transformations during oxidation of peptides and proteins: Modifications of methionine and tyrosine. Anal Chem 67:390-398.
15. DalleDonne I, Milzani A, Colombo R 1999 The tert-butyl hydroperoxide-induced oxidation of actin Cys-374 is coupled with structural changes in distant regions of the protein. Biochemistry 38:12471-12480.
16. 2. J Biol Chem 269:2405-2410.
17. Sendak RA, Wang F, Geagan LB, Armstrong LA, Thyne CD, Cole ES, Mattaliano RJ 2002 Comparison of two in vitro methods for the measurement of recombinant human TSH bioactivity. Biologicals 30:245-254.
18. Ladenson PW, Braverman LE, Mazzaferri EL, Brucker-Davis F, Cooper DS, Garber JR, Wondisford FE, Davies TF, DeGroot LJ, Daniels GH, Ross DS, Weintraub BD, Hay ID, Levis S, Reynolds JC, Robbins J, Becker DV, Cavalieri RR, Maxon HR, McEllin K, Moscicki R 1997 Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 337:888-896.
19. Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, Cooper DS, Graham KE, Braverman LE, Skarulis MC, Davies TF, DeGroot LJ, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Becker DV, Maxon HR III, Cavalieri RR, Spencer CA, McEllin K, Weintraub BD, Ridgway EC 1999 A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 84:3877-3885.
20. Huang J, Chen F, Puett D 1993 Amino/carboxyl-terminal deletion mutants of human choriogonadotropin 6. J Biol Chem 268:9311-9315.
21. Lapthorn AJ, Harris DC, Littlejohn A, Lustbader JW, Canfield RE, Machin KJ, Morgan FJ, Isaacs NW 1994 Crystal structure of human chorionic gonadotropin. Nature 369:455-461.